Expression of p53 in arsenic-related and sporadic basal cell carcinoma

Boonchai, Waranya, Walsh, Michael, Cummings, Margaret and Chenevix-Trench, Georgia (2000) Expression of p53 in arsenic-related and sporadic basal cell carcinoma. Archives of Dermatology, 136 2: 195-198. doi:10.1001/archderm.136.2.195

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
UQ139327_OA.pdf Full text (open access) application/pdf 219.46KB 0

Author Boonchai, Waranya
Walsh, Michael
Cummings, Margaret
Chenevix-Trench, Georgia
Title Expression of p53 in arsenic-related and sporadic basal cell carcinoma
Journal name Archives of Dermatology   Check publisher's open access policy
ISSN 0003-987X
Publication date 2000-02
Sub-type Article (original research)
DOI 10.1001/archderm.136.2.195
Open Access Status File (Publisher version)
Volume 136
Issue 2
Start page 195
End page 198
Total pages 4
Place of publication Chicago
Publisher American Medical Association
Collection year 2000
Language eng
Subject C1
321015 Oncology and Carcinogenesis
730108 Cancer and related disorders
Abstract Background: The TP53 gene has been shown to have an important role in the genesis of sporadic, presumably mainly sunlight-related, basal cell carcinoma (BCC). However, its role in arsenic-related BCCs is not clear, although the trivalent form of arsenic has been long recognized as a cause of BCC. Arsenic treatment has been shown to cause hypermethylation of the TP53 gene in lung carcinoma cell lines, but it is not known if this occurs in vivo in arsenic-related BCCs. Objective: To compare the immunohistochemical expression of the p53 protein in arsenic-related and sporadic BCCs to determine if the expression pattern is consistent with gene silencing. Setting: A research institute and hospital in Australia. Cases: One hundred seventeen white patients with 121 sporadic BCCs and 21 white patients with 92 arsenic-related BCCs. Main Outcome Measures: The expression and the in-tensity of p53 were scored semiquantitatively. Statistical analysis was performed using the chi(2) test. Results: Arsenic-related BCCs express p53 less often and at a lower intensity than sporadic BCCs (P = .001; 2-tailed test). The BCCs from sun-exposed sites, whether arsenic related or sporadic, more frequently showed overexpression of p53 than those from less-exposed areas (P = .004, 2-tailed test). The more aggressive subtypes of BCC show a higher level of expression of p53 than the less aggressive forms (P = .04; 2-tailed chi(2) test). Conclusions: These results are consistent with the hypothesis that the TP53 gene is down-regulated by methylation in arsenic-related BCC, particularly those from less-exposed sites. However, an alternative possibility is that mutations in TP53 that stabilize the protein are less common in arsenic-related BCCs. Further analysis will be necessary to distinguish between these hypotheses.
Keyword Dermatology
Skin Cancers
Australian Population
Q-Index Code C1

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Medicine Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 36 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Tue, 10 Jun 2008, 10:32:53 EST